4,6-Dimethyl-N-[(3R)-3-pyrrolidinyl]-2-pyrimidinamine hydrochloride (1:1)(CAS: 1289584-90-2)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires specific handling, storage, and disposal guidelines. Additionally, it complies with REACH regulations in the European Union, which mandate detailed documentation on safety data sheets (SDS) and registration. For use in the United States, it must meet FDA and EPA requirements, including proper labeling and handling to prevent environmental contamination.

Several alternatives exist for synthesizing similar functionalities, such as other pyrimidinamine derivatives like 4,6-dimethyl-2-pyrimidinamine or related pyrimidine compounds. Isomers or analogs with similar structures might also be used as substitutes, depending on the specific requirements of the synthesis. Common alternative reagents include different amines or pyrimidine precursors.

The market for this compound is primarily driven by its use in pharmaceutical research, particularly as a precursor or intermediate in drug development. Research trends indicate a growing interest in its potential applications in anti-inflammatory and antiviral therapies. The compound's demand is expected to rise with advancements in synthetic methodologies and its integration into novel drug discovery pipelines.

Waste containing this compound should be collected in appropriate, labeled containers and disposed of according to local regulations. For safe disposal, professional incineration or chemical-neutralization methods are recommended. Environmental protection measures include ensuring no leakage occurs and using protective equipment during handling. Proper documentation of waste disposal and management is crucial to comply with environmental laws and regulations.